Ocugen (OCGN) Income towards Parent Company (2014 - 2026)

Ocugen (OCGN) reported Income towards Parent Company of -$19.1 million for Q1 2026, down 23.3% on a YoY basis from -$24.8 million in Q1 2025, and down 4.69% quarter-over-quarter from -$18.2 million in Q4 2025.

Ocugen (OCGN) Income towards Parent Company (2014 - 2026) Analysis & Trends

Ocugen has reported Income towards Parent Company for 13 years, with the latest figure at -$19.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company fell 23.3% year-over-year to -$19.1 million; the trailing twelve-month figure through Mar 2026 stood at -$70.8 million (down 22.71% YoY), and the FY2025 full-year result was -$67.2 million, down 23.97% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$19.1 million, down from -$18.2 million in the prior quarter.
  • The five-year high for Income towards Parent Company was -$11.5 million in Q4 2023, with the low at -$23.5 million in Q2 2023.
  • Historically, Income towards Parent Company has averaged -$17.1 million across 5 years, with a median of -$18.0 million in 2023.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company plunged 168.9% — and 2023, when it surged 47.47%.
  • Ocugen's Income towards Parent Company stood at -$21.9 million in 2022, then jumped by 47.47% to -$11.5 million in 2023, then slipped by 21.76% to -$14.0 million in 2024, then decreased by 29.73% to -$18.2 million in 2025, then dropped by 4.69% to -$19.1 million in 2026.
  • The last three Income towards Parent Company figures came in at -$19.1 million (Q1 2026), -$18.2 million (Q4 2025), and -$18.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Ocugen 411.07 Mn 411.07 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.06 Mn
Dec 31, 2025 -18.21 Mn
Sep 30, 2025 -18.73 Mn
Jun 30, 2025 -14.85 Mn
Mar 31, 2025 -15.46 Mn
Dec 31, 2024 -14.03 Mn
Sep 30, 2024 -12.97 Mn
Jun 30, 2024 -15.28 Mn
Mar 31, 2024 -11.91 Mn
Dec 31, 2023 -11.53 Mn
Sep 30, 2023 -12.43 Mn
Jun 30, 2023 -23.54 Mn
Mar 31, 2023 -18.04 Mn
Dec 31, 2022 -21.94 Mn
Sep 30, 2022 -21.92 Mn
Jun 30, 2022 -21.58 Mn
Mar 31, 2022 -19.03 Mn
Dec 31, 2021 -14.58 Mn
Sep 30, 2021 -10.76 Mn
Jun 30, 2021 -25.62 Mn